XML 54 R35.htm IDEA: XBRL DOCUMENT v3.26.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2025
Summary of Significant Accounting Policies [Abstract]  
Schedule of Estimated Useful Lives

The estimated useful lives are:

 

Laboratory equipment   5 – 10 years
Office equipment   3 – 10 years
Schedule of Disaggregate Revenue

Disaggregated revenue for the years ended December 31, 2025 and 2024 as follows:

 

   Years ended 
   December 31, 
   2025   2024 
Genetic diagnostic testing kits  $480,131   $865,516 
Instrumentation rental income   56,949    28,475 
   $537,080   $893,991 
Schedule of Computation of Diluted Net Loss Per Share

For the years ended December 31, 2025, and 2024, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result was anti-dilutive.

 

   Years ended 
   December 31, 
   2025   2024 
Stock options   449,480    54,355 
Warrants   8,805,020    2,839,208 
Convertible debt   10,391    102,464 
    9,264,891    2,996,027